Introduction
Aging is a primary risk factor in several neurodegenerative disorders, including Parkinson's disease (PD).
PD is the second most common neurodegenerative disease. It is characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN) [14] . It is predicted that PD affects over 1% of the population at age 60, but the rate of PD is five times higher by age 80, suggesting that senescence of the brain or neurons is related to the onset of PD [2] [9] [16] . Although it remains unclear how aging causes the malfunctioning of protein quality control system in neurons, the appearance of cytoplasmic inclusions such as Lewy bodies and pale bodies, hallmarks of late-onset sporadic and familial PD and dementia with Lewy bodies (DLB) [4] , suggests there is a close relationship between protein inclusions and neuronal death.
Lu et al. [6] have demonstrated that the repressor element-1 silencing transcription factor (REST), also known as neuron-restrictive silencer factor (NRSF), is transcriptionally induced in the aging human A C C E P T E D M A N U S C R I P T brain, and induction is decreased in patients with Alzheimer's disease (AD). They also showed that induced REST is localized in the nucleus, where it represses the transcription of pro-apoptotic and AD-related proteins in normal aging brain, suggesting that REST induction and nuclear accumulation is neuroprotective.
On the other hand, REST is a primary factor in the transcriptional and epigenetic regulatory circuitry that modulates the expression of genes containing the neuron-restrictive silencer element (NRSE) in their promoter region [1] [13] . Since NRSE is found in most neuron-specific genes, REST is believed to act exclusively in non-neuronal cells where it represses the expression of NRSF-controlled neuron-specific genes [8] . If REST only represses neuronal genes, REST induction and nuclear accumulation in aging neurons would be injurious. Thus, it is important to clarify which situation occurs and identify the neuroprotective functions of REST in aging and PD brains.
Material and Methods

Antibodies
Anti-REST antibodies (Bethyl Lab IHC-00141, Millipore 07-579), anti-TH antibody (Sigma T2928), anti-p62 antibody (Progen p62C), anti-ubiquitin antibody (FK2 04-263), anti-LDH antibody (Santa Cruz H-160 sc-33781), anti-XRCC1 antibody (Cell Signaling Technology #2735S) were purchased.
Human brain sections
Postmortem human brain tissue (n=14) was obtained from Juntendo University Hospital and the Jikei University Hospital (Table 1) . Human brain samples included the SN and cortex.
Animals
All animals were kept in a pathogen-free and odor-free environment, which was maintained under a 12 h 
Immunohistochemical analysis
After fixation with 10% neutral phosphate-buffered formalin, 6-µm-thick paraffin embedded tissue sections were cut and stained with hematoxylin and eosin. For immunohistochemistry (IHC), we used antibodies 
Results
To determine whether the REST is located in the nucleus in neurons of a normal, aging human brain, Figure 1A) , we found that only the Bethyl antibody could detect REST in postmortem human samples. In previous studies, this antibody has shown reactivity against the full-length REST protein in neurons [6] [12] . In cortical neurons of normal aging human brain, REST immunoreactivity was distributed throughout the cell, including the nucleus in most cases, suggesting that REST enters the nucleus of senescent neurons and could be a marker for neuronal senescence.
Next, we investigated whether REST could be detected in dopaminergic SN neurons. In middle-aged cases (age 47 and 61 years), REST was not observed in the nucleus and there was a small amount of cytosolic accumulation ( Figure 1A ). In elderly cases (age 72, 79 and 81 years), REST was observed in both the nucleus and cytosol ( Figure 1B) , suggesting that nuclear entry of REST is senescence-dependent. This observation was consistent with previous results, in which a cytoplasmic distribution of REST was observed without nuclear staining in neurons in the cortex, caudate nucleus, cerebellum, and hippocampus in cases
aged 44-60 years [12] . These results indicate that nuclear accumulation of REST is a universal feature of senescent neurons. In contrast to control cases, REST immunoreactivity in patients with PD and DLB was decreased in dopaminergic SN neurons (Figure 2A-E) and in cortical neurons ( Figure 2F) . Importantly, the REST signal was strongly detected in Lewy bodies and pale bodies ( Figure 2C-F) . Since a previous report showed that REST is incorporated into cytoplasmic protein aggregates in the cortical neurons of patients with AD, DLB, and FTD [6] , it is consistent with our result that REST was detected in Lewy bodies and pale bodies. These results suggest that protein inclusions have a propensity to sequester the REST protein and may prevent senescence-dependent nuclear entry.
Disease-related aggregation-prone proteins such as alpha-synuclein in PD, Aβ or Tau in AD, huntingtin in Huntington's disease (HD), and TDP-43 in frontotemporal dementia (FTD) have a tendency to form amyloid-like structures and protein aggregates because of their stable structure in the misfolded state.
These aggregates generated in a cell contain many kinds of ubiquitinated proteins and p62/SQSTM1, which is known as the major autophagy receptor for selective autophagy [5, 15] . To determine whether REST has a propensity to interact with ubiquitinated protein aggregates that are not aggregation-prone, we evaluated REST localization in the brain of dopaminergic neuron-specific Atg7 conditional knockout mice (Atg7 flox/flox :TH-Cre) [11] . In the SN of control mice aged 12 months, REST and p62 immunoreactivity was under the detection limit in tyrosine hydroxylase (TH)-positive neurons (Figure 3Af-j) . Of note, we used the Figure 3B) . In neuronal cells, the transcribed REST RNA is processed by neuron specific splicing complex and converted into neuron specific variant, REST4 [10] . Because the primer set 1 amplifies both mRNAs of full-length REST and neuron specific splicing variant, REST4, but primer set 2 and 3 do only the full-length REST mRNA, increased amounts of
REST transcripts by MG132 treatment may be spliced into the REST4 mRNA. The immunoblot analysis revealed that 10 µM MG132 treatment resulted in the accumulation of REST protein, but not the more proteasome specific inhibitor, lactacystin, treatment, supporting the idea that REST is degraded through autophagy-lysosome pathway ( Figure 3D ), because high concentration of MG132 inhibits both proteasomaland lysosomal-protein degradation. Intriguingly, interfering with the electron transport chain in mitochondria by Rotenone treatment reduced the REST accumulation. As rotenone is a possible Parkinson-causing agent, loss of neuronal REST accumulation in aged-neurons may relate to the PD pathology.
Discussion
In this study, we demonstrated nuclear accumulation of REST in cortical and SN neurons in the normal aging human brain using immunohistochemistry. On the other hand, REST immunoreactivity was observed in Lewy bodies and pale bodies in the postmortem human brain of patients with DLB and PD. We recently reported that Atg7 flox/flox :TH-Cre mice demonstrate neuronal loss and typical Lewy body disease pathology, including p62, ubiquitin, and synuclein, a pattern which resembles PD [11] . In addition, as these mice age, Senescence-induced REST expression may result in its nuclear accumulation and repression of target genes, which may differ from conventional neuron-specific genes. It needs to be clarified if REST plays critical roles of neuronal survival in aged-human brain and relates to the PD pathology.
In conclusion, nuclear accumulation of REST occurs as a normal aging process and Lewy pathology disturbs the process in dopaminergic neurons by sequestering REST. The alteration of neuronal aging processes including the loss of REST in neurons may associate with the PD pathogenesis.
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